Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Taro Pharm Inds (NY: TARO ) 42.97 UNCHANGED Last Price Updated: 7:00 PM EDT, Jun 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Taro Pharm Inds < Previous 1 2 Next > Taro Provides Results for Year Ended March 31, 2024 May 20, 2024 From Taro Pharmaceutical Industries Ltd. Via Business Wire Taro to Release Full Year Results on May 20, 2024 May 15, 2024 From Taro Pharmaceutical Industries Ltd. Via Business Wire Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma Merger May 08, 2024 From Taro Pharmaceutical Industries Ltd. Via Business Wire TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Taro Pharmaceutical Industries Ltd. - TARO April 22, 2024 From Kahn Swick & Foti, LLC Via Business Wire Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd. April 15, 2024 From Taro Pharmaceutical Industries Ltd. Via Business Wire TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Taro Pharmaceutical Industries Ltd. - TARO February 06, 2024 From Kahn Swick & Foti, LLC Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Rover Group, Inc. (Nasdaq - ROVR), M.D.C. Holdings, Inc. (NYSE - MDC), Taro Pharmaceutical Industries Ltd. (NYSE - TARO), PGT Innovations Inc. (NYSE - PGTI) January 26, 2024 From Brodsky & Smith LLC Via GlobeNewswire Taro Provides Results for December 31, 2023 January 25, 2024 From Taro Pharmaceutical Industries Ltd. Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Rover Group, Inc. (Nasdaq - ROVR), M.D.C. Holdings, Inc. (NYSE - MDC), Taro Pharmaceutical Industries Ltd. (NYSE - TARO), PGT Innovations Inc. (NYSE - PGTI) January 22, 2024 From Brodsky & Smith LLC Via GlobeNewswire Taro to Release Third Quarter Results on January 25, 2024 January 19, 2024 From Taro Pharmaceutical Industries Ltd. Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: M.D.C. Holdings, Inc. (NYSE - MDC), Cornerstone Financial Corporation (OTC - CFIC), Taro Pharmaceutical Industries Ltd. (NYSE - TARO), PGT Innovations Inc. (NYSE - January 18, 2024 From Brodsky & Smith LLC Via GlobeNewswire TARO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Taro Pharmaceutical Industries Ltd. Is Fair to Shareholders January 17, 2024 From Halper Sadeh LLC Via Business Wire Taro Provides Results for September 30, 2023 October 26, 2023 From Taro Pharmaceutical Industries Ltd. Via Business Wire Taro to Release Second Quarter Results on October 26, 2023 October 19, 2023 From Taro Pharmaceutical Industries Ltd. Via Business Wire Taro Provides Results for the Quarter Ended June 30, 2023 July 26, 2023 From Taro Pharmaceutical Industries Ltd. Via Business Wire Taro to Release First Quarter Results on July 26, 2023 July 19, 2023 From Taro Pharmaceutical Industries Ltd. Via Business Wire Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2023 June 30, 2023 From Taro Pharmaceutical Industries Ltd. Via Business Wire Taro Pharmaceutical Industries Ltd. (NYSE: TARO) Near the Top of Equities by Percentage Gain on 5/30 May 30, 2023 Via Investor Brand Network Taro Provides Results for Year Ended March 31, 2023 May 23, 2023 From Taro Pharmaceutical Industries Ltd. Via Business Wire Taro to Release Full Year Results on May 23, 2023 May 18, 2023 From Taro Pharmaceutical Industries Ltd. Via Business Wire Taro Provides Results for December 31, 2022 January 24, 2023 From Taro Pharmaceutical Industries Ltd. Via Business Wire Taro to Release Third Quarter Results on January 24, 2023 January 19, 2023 From Taro Pharmaceutical Industries Ltd. Via Business Wire Taro Provides Results for September 30, 2022 October 27, 2022 From Taro Pharmaceutical Industries Ltd. Via Business Wire Taro to Release Second Quarter Results on October 27, 2022 October 24, 2022 From Taro Pharmaceutical Industries Ltd. Via Business Wire Taro Provides Results for the Quarter Ended June 30, 2022 July 27, 2022 From Taro Pharmaceutical Industries Ltd. Via Business Wire Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2022 July 26, 2022 From Taro Pharmaceutical Industries Ltd. Via Business Wire Taro to Release First Quarter Results on July 27, 2022 July 26, 2022 From Taro Pharmaceutical Industries Ltd. Via Business Wire Taro Provides Results for the Year Ended March 31, 2022 May 26, 2022 From Taro Pharmaceutical Industries Ltd. Via Business Wire Taro to Announce Full Year Results on May 26, 2022 May 20, 2022 From Taro Pharmaceutical Industries Ltd. Via Business Wire Taro to Acquire Alchemee From Galderma February 22, 2022 From Galderma Via Business Wire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.